Dr.med. ID: 48118

Johann Felden

graph of relations

Publications

  1. 2018
  2. High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma

    D'Avola, D., Villacorta-Martin, C., Martins-Filho, S. N., Craig, A., Labgaa, I., von Felden, J., Kimaada, A., Bonaccorso, A., Tabrizian, P., Hartmann, B. M., Sebra, R., Schwartz, M. & Villanueva, A., 01.08.2018, In: SCI REP-UK. 8, p. 11570

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

    Labgaa, I., Villacorta-Martin, C., D'Avola, D., Craig, A. J., von Felden, J., Martins-Filho, S. N., Sia, D., Stueck, A., Ward, S. C., Fiel, M. I., Mahajan, M., Tabrizian, P., Thung, S. N., Ang, C., Friedman, S. L., Llovet, J. M., Schwartz, M. & Villanueva, A., 07.2018, In: ONCOGENE. 37, 27, p. 3740-3752 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis

    Stickel, F., Buch, S., Nischalke, H. D., Weiss, K. H., Gotthardt, D., Fischer, J., Rosendahl, J., Marot, A., Elamly, M., Casper, M., Lammert, F., McQuillin, A., Zopf, S., Spengler, U., Marhenke, S., Kirstein, M. M., Vogel, A., Eyer, F., von Felden, J., Wege, H., Buch, T., Schafmayer, C., Braun, F., Deltenre, P., Berg, T., Morgan, M. Y. & Hampe, J., 07.2018, In: AM J GASTROENTEROL. 113, 7, p. 1099

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  5. Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma

    von Felden, J., Craig, A. J. & Villanueva, A., 07.2018, In: Oncoscience. 5, 7-8, p. 209-211 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Editorial: genotype 3 HCV-who still needs ribavirin in a pan-genotypic era? Authors' reply.

    von Felden, J., Vermehren, J., Schulze Zur Wiesch, J., Sarrazin, C. & Christensen, S., 06.2018, In: ALIMENT PHARM THER. 47, 11, p. 1550-1551 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  7. High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection

    von Felden, J., Vermehren, J., Ingiliz, P., Mauss, S., Lutz, T., Simon, K. G., Busch, H. W., Baumgarten, A., Schewe, K., Hueppe, D., Boesecke, C., Rockstroh, J. K., Daeumer, M., Luebke, N., Timm, J., Schulze Zur Wiesch, J., Sarrazin, C. & Christensen, S., 05.2018, In: ALIMENT PHARM THER. 47, 9, p. 1288-1295 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis

    Hartl, J., Ehlken, H., Sebode, M., Peiseler, M., Krech, T., Zenouzi, R., von Felden, J., Weiler-Normann, C., Schramm, C. & Lohse, A. W., 04.2018, In: J HEPATOL. 68, 4, p. 754-763 10 p., 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals

    Debes, J. D., van Tilborg, M., Groothuismink, Z. M. A., Hansen, B. E., Schulze Zur Wiesch, J., von Felden, J., de Knegt, R. J. & Boonstra, A., 02.2018, In: GASTROENTEROLOGY. 154, 3, p. 515-517

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Successful treatment of chronic hepatitis C with ground ledipasvir/sofosbuvir in a patient with Crohn's disease and short bowel syndrome

    von Felden, J., Scheurich, C., Yamamura, J., Brainard, D. M., Mogalian, E., Lohse, A. W. & Schulze Zur Wiesch, J., 02.2018, In: J VIRAL HEPATITIS. 25, 2, p. 214-215 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  11. 2017
  12. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection

    von Felden, J., Schulze, K., Krech, T., Ewald, F., Nashan, B., Pantel, K., Lohse, A. W., Riethdorf, S. & Wege, H., 27.10.2017, In: ONCOTARGET. 8, 52, p. 89978-89987 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Molecular profiling of liver cancer heterogeneity

    Craig, A. J., von Felden, J. & Villanueva, A., 09.2017, In: DISCOV MED. 24, 131, p. 117-125 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection

    von Felden, J., Heim, D., Schulze, K., Krech, T., Ewald, F., Nashan, B., Lohse, A. W. & Wege, H., 18.01.2017, In: BMC CANCER. 17, 1, p. 60

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. 2016
  16. First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response Evaluation

    von Felden, J., Schulze, K., Gil-Ibanez, I., Werner, T. & Wege, H., 28.11.2016, In: DIAGNOSTICS. 6, 4, p. E44

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. 2015
  18. MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis

    Limbourg, A., von Felden, J., Jagavelu, K., Krishnasamy, K., Napp, L. C., Kapopara, P. R., Gaestel, M., Schieffer, B., Bauersachs, J., Limbourg, F. P. & Bavendiek, U., 2015, In: PLOS ONE. 10, 10, p. e0138542

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. 2014
  20. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury

    Kapopara, P. R., von Felden, J., Soehnlein, O., Wang, Y., Napp, L. C., Sonnenschein, K., Wollert, K. C., Schieffer, B., Gaestel, M., Bauersachs, J. & Bavendiek, U., 12.2014, In: THROMB HAEMOSTASIS. 112, 6, p. 1264-76 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Mitogen-activated protein kinase-activated protein kinase 2 deficiency reduces insulin sensitivity in high-fat diet-fed mice

    de Boer, J. F., Dikkers, A., Jurdzinski, A., von Felden, J., Gaestel, M., Bavendiek, U. & Tietge, U. J. F., 2014, In: PLOS ONE. 9, 9, p. e106300

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. 2013
  23. Drug-induced acute liver injury mimicking autoimmune hepatitis after intake of dietary supplements containing glucosamine and chondroitin sulfate

    von Felden, J., Montani, M., Kessebohm, K. & Stickel, F., 03.2013, In: INT J CLIN PHARM TH. 51, 3, p. 219-23 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. 2012
  25. Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice

    Schuett, H., Oestreich, R., Waetzig, G. H., Annema, W., Luchtefeld, M., Hillmer, A., Bavendiek, U., von Felden, J., Divchev, D., Kempf, T., Wollert, K. C., Seegert, D., Rose-John, S., Tietge, U. J. F., Schieffer, B. & Grote, K., 02.2012, In: ARTERIOSCL THROM VAS. 32, 2, p. 281-90 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next